Rudy Dekeyser 21/04/05. origin of the species mission & objectives creating an innovative environment is basic high quality research compatible with tech.
Adenomyosis Sun-Wei Guo Shanghai OB/GYN Hospital Fudan University.
Ru-Band Lu, MD. Shiou-Lan Chen, PhD. National Cheng Kung University Neuro-degeneration and Novel Treatment in Heroin dependence.
Jefferies 2010 Healthcare Conf
Mesenchymal Stem Cells Associated With Porous Chitosan Gelatin Scaffold a Potential Strategy for Alveolar Bone Regeneration 2012
Innovation in Nutritional Treatment for Dysphagia Thérèse Dufresne, RD.
At this presentation we introduce a new challenge to developing a novel treatment for HIV Under Title the Antibodies of Reverse Transcriptase System.
Infection as a treatable cause for asthma- Where do we go from here? David L Hahn, MD MS Workshop - September 2012.
Pre-randomisation consent (Zelen’s method). Background Most individually randomised trials ask patient CONSENT before randomisation. There are problems.
Dr. Emmanuel Abara FRCS(C) FACS FICS Richmond Hill Urology Practice & Prostate Institute (RHUPPI) Northern Ontario School of Medicine (NOSM)
Infection as a treatable cause for asthma- Where do we go from here?
Update on primary sclerosing cholangitis
